Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Experimental Hematology

• Publication date

  1999-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0301-472X(99)00100-9PMID 10560907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Activation of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Receptor Subunits in a Multipotential Hematopoietic Progenitor Cell Line Leads to Differential Effects on Development

  1999cited by this paper
• Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice.

  1999cited by this paper
• Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.

  1999cited by this paper
• Activation of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development.

  1999cited by this paper
• BCR – ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

  1998cited by this paper
• Granulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils

  1998cited by this paper
• An Activated Protein Kinase C α Gives a Differentiation Signal for Hematopoietic Progenitor Cells and Mimicks Macrophage Colony-stimulating Factor–stimulated Signaling Events

  1998cited by this paper
• Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.

  1998cited by this paper
• Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation

  1998cited by this paper
• Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor.

  1998cited by this paper
• Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines

  1998cited by this paper
• Ras versus cyclin-dependent kinase inhibitors.

  1998cited by this paper
• Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).

  1997cited by this paper
• Transcription factors, normal myeloid development, and leukemia.

  1997cited by this paper
• Involvement of STAT3 in the Granulocyte Colony-stimulating Factor-induced Differentiation of Myeloid Cells*

  1997cited by this paper
• Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells

  1997cited by this paper
• Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors.

  1996cited by this paper
• Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner.

  1996cited by this paper
• Granulocyte-macrophage Colony-stimulating Factor Provokes RAS Activation and Transcription of c-fos through Different Modes of Signaling (*)

  1996cited by this paper
• Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells.

  1996cited by this paper
• Mutations of ras genes in human tumors (review).

  1995cited by this paper
• Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.

  1995cited by this paper
• Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells.

  1995cited by this paper
• Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

  1995cited by this paper
• Growth factor requirements for normal and leukemic cells.

  1995cited by this paper
• Erythroid development of the FDCP‐Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3

  1995cited by this paper
• Cytokine-mediated protein kinase C activation is a signal for lineage determination in bipotential granulocyte macrophage colony-forming cells

  1994cited by this paper
• Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells.

  1994cited by this paper
• Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.

  1994cited by this paper
• Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells.

  1993cited by this paper
• Haemopoietic stem cell development to neutrophils is associated with subcellular redistribution and differential expression of protein kinase C subspecies.

  1993cited by this paper
• Molecular genetic aspects of myelodysplastic syndromes.

  1992cited by this paper
• The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells.

  1990cited by this paper
• Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).

  1989cited by this paper
• Reversible abrogation of IL‐3 dependence by an inducible H‐ras oncogene.

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia

  1989cited by this paper
• Expression of normal and mutant ras proteins in human acute leukemia.

  1987cited by this paper
• A pragmatic approach to the analysis of DNA histograms with a definable G1 peak.

  1987cited by this paper
• Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors.

  1986cited by this paper

• Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome

  2020cites this paper
• MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma

  2018cites this paper
• Mediated by Ras Inhibition of Myeloid Differentiation Ral Is both Necessary and Sufficient for the

  2014cites this paper
• N-ras Mutation Detection by Pyrosequencing in Adult Patients with Acute Myeloid Leukemia at a Single Institution

  2013cites this paper
• RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia.

  2013cites this paper
• Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia

  2013cites this paper
• A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer

  2012cites this paper
• RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group

  2012cites this paper
• Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.

  2009cites this paper
• Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy

  2009cites this paper
• Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.

  2009cites this paper
• Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders.

  2007cites this paper
• N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.

  2007cites this paper
• Ral Is both Necessary and Sufficient for the Inhibition of Myeloid Differentiation Mediated by Ras

  2006influential citation
• Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

  2006cites this paper
• Regulation of the potential tumorsuppressor gene mad1 by G-CSF

  2006cites this paper
• RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.

  2005cites this paper
• RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

  2005cites this paper
• Chronic myelomonocytic leukemia: lost in classification?

  2005cites this paper
• Leukemia Cells and the Cytokine Network: Therapeutic Prospects

  2004cites this paper
• Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.

  2004cites this paper
• Hematopoietic Cell Fate and the Initiation of Leukemic Properties in Primitive Primary Human Cells Are Influenced by Ras Activity and Farnesyltransferase Inhibition

  2004cites this paper
• Reviews of Physiology, Biochemistry and Pharmacology

  2003cites this paper
• Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.

  2003cites this paper
• 7,12-DMBA-induced rat leukemia: a review with insights into future research.

  2002cites this paper
• Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristics

  2002cites this paper
• BCR–ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

  2002cites this paper
• Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins.

  2001cites this paper
• Mutations in ras proto‐oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia

  2001influential citation